Navigation Links
Global Biofuels Growth to Double by 2015
Date:9/30/2009

rcial operations.

"Be it cellulosic ethanol, renewable diesel, biomass-to-liquids (BTL) or Fischer Tropsch liquids, made from feedstocks such as agricultural or municipal solid wastes, grasses, woods, waste paper and algae, next-generation biofuels are still largely under Research & Development," said Tammy Klein, Executive Director of the Global Biofuels Center and the study leader.

Moreover, the study finds, mandates set that require next generation biofuels will not be met, particularly in the U.S. Currently, sugarcane ethanol from Brazil is the only commercially available, economical, low-carbon biofuel available on the market currently to meet U.S. RFS2 advanced biofuel and other low- carbon fuel requirements.

Other key findings include:

  • Global ethanol demand will represent 12-14% of the global gasoline pool by 2015;
  • Asia-Pacific ethanol production will grow tremendously in the coming years and could represent as much as 20% of global ethanol production by 2015;
  • Of note, if India's own projections were realized, it could outpace Brazil in ethanol production and exporting by 2015. Nonetheless, despite India's ethanol production expansion Hart projects that Brazil will remain the leading global biofuels exporter.

Covering mainly ethanol and biodiesel, but also ETBE (ethyl tertiary butyl ether), cellulosic ethanol and renewable diesel (also known as non-ester biodiesel) where applicable, the Global Biofuels Outlook captures the current and near-term biofuels picture in 35 countries in the five key regions of the globe. The study reviews local and global drivers, public and fiscal policy developments, current and projected production capacity, and supply and demand projections for 2009, 2010 and 2015. This year, the study also includes a comprehensive matrix of next
'/>"/>

SOURCE Hart Energy Publishing
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)...   Cypher Genomics, Inc., the leading genome ... SQNM ), the leading molecular diagnostics company, today ... prenatal tests (NIPT). Through this agreement, Sequenom will ... advance analysis of clinically-relevant fetal sub-chromosomal variants detected ...
(Date:1/22/2015)... Jan. 22, 2015   GenoSpace , a precision medicine software ... enable the broad use of genomic, imaging and other biomedical ... of Michelle Munson , CEO of Aspera, an IBM ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We are ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 The report ... by Product Type & Provider Type - Global Advancements, ... market with an in-depth analysis and forecasting of revenues. ... spread through 221 pages and in-depth TOC on “Service ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, ... announced the closing of an underwritten public offering of 3,500,000 ... an aggregate 3,500,000 shares of common stock, at an offering ... warrants have a per share exercise price of $5.00, are ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4GenoSpace Expands Board with Appointment of Michelle Munson 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... CHAPEL HILL, N.C., June 18 To thrive ... need to,understand that a winning sales performance doesn,t ... their sales forces, then,measure the forces, field-performance to ... research study reveals that best-in-class,companies allow their sales ...
... Arsenal Against ... Chronic Wounds, ... provider of advanced wound care products,announced today that its key product, ... by clinicians at Georgetown,University Hospital,s Wound Center to save a patient,s ...
... Pharmaceuticals, Inc., a,privately held biopharmaceutical company specializing in ... ophthalmology, is pleased,to announce the appointment of Dr. ... "I am honored and delighted to join ... as it advances its lead programs through,clinical trials ...
Cached Biology Technology:Increasing Sales Productivity Through Superior Sales Force Performance Management 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 2Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 3Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb 4Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 2Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals 3
(Date:12/19/2014)... Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has announced the ... Apple/AuthenTec TMDR92 & Sapphire - Technology Report" report ... Following the acquisition of AuthenTec in ... the iPhone 5S. It is currently the only device ...
(Date:12/17/2014)... Va. , Dec. 15, 2014 The Defense ... easier to detect and prevent counterfeit microcircuits from entering ... started performing an in-house microcircuit anti-counterfeit initiative dubbed DNA ... microcircuits while increasing their reliability throughout the supply chain. ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used for the ... facial feature of a person such as nose, jaw ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... mediates the body's defense against a wide variety of infectious ... as the result of a new study by researchers at ... "Essentially, we found a way to grease the gears that ... Selma and Herman Seldin Professor of Medicine and director of ...
... expression of a special green-algae gene into neurons ... have been able to elicit specific behavioral responses ... work paves the way for better understanding of ... muscles, to regulate behavior in intact, living organisms. ...
... In a surprise twist that recalls the film classic "Flowers ... statins, a popular class of cholesterol drugs, to reverse the ... disabilities. The Nov. 8 issue of Current Biology reports ... the disease, called neurofibromatosis 1 (NF1). , The ...
Cached Biology News:Greasing interferon's gears may pave way to greater therapeutic benefits, fewer side effects 2Algal protein in worm neurons allows remote control of behavior by light 2Recreating 'Flowers for Algernon' with a happy ending 2Recreating 'Flowers for Algernon' with a happy ending 3